Multitaper estimates of phase-amplitude coupling

Unsupervised Multitaper Spectral Method for Identifying REM Sleep in Intracranial EEG Recordings Lacking EOG/EMG Data

A large number of human intracranial EEG (iEEG) recordings have been collected for clinical purposes, in institutions all over the world, but the vast majority of these are unaccompanied by EOG and EMG recordings which are required to separate Wake episodes from REM sleep using accepted methods. In order to make full use of this extremely valuable data, an accurate method of classifying sleep from iEEG recordings alone is required. Existing methods of sleep scoring using only iEEG recordings accurately classify all stages of sleep, with the exception that wake (W) and rapid-eye movement (REM) sleep are not well distinguished. A novel multitaper (Wake vs. REM) alpha-rhythm classifier is developed by generalizing K-means clustering for use with multitaper spectral eigencoefficients. The performance of this unsupervised method is assessed on eight subjects exhibiting normal sleep architecture in a hold-out analysis and is compared against a classical power detector. The proposed multitaper classifier correctly identifies 36±6 min of REM in one night of recorded sleep, while incorrectly labeling less than 10% of all labeled 30 s epochs for all but one subject (human rater reliability is estimated to be near 80%), and outperforms the equivalent statistical-power classical test. Hold-out analysis indicates that when using one night's worth of data, an accurate generalization of the method on new data is likely. For the purpose of studying sleep, the introduced multitaper alpha-rhythm classifier further paves the way to making available a large quantity of otherwise unusable IEEG data.

Oscillatory beta dynamics inform biomarker-driven treatment optimization for Parkinson's disease

Parkinson's disease (PD) is a neurodegenerative disorder characterized by loss of dopaminergic neurons and dysregulation of the basal ganglia. Cardinal motor symptoms include bradykinesia, rigidity, and tremor. Deep brain stimulation (DBS) of select subcortical nuclei is standard of care for medication-refractory PD. Conventional open-loop DBS delivers continuous stimulation with fixed parameters that do not account for a patient's dynamic activity state or medication cycle. In comparison, closed-loop DBS, or adaptive DBS (aDBS), adjusts stimulation based on biomarker feedback that correlates with clinical state. Recent work has identified several neurophysiological biomarkers in local field potential recordings from PD patients, the most promising of which are 1) elevated beta (∼13-30 Hz) power in the subthalamic nucleus (STN), 2) increased beta synchrony throughout basal ganglia-thalamocortical circuits, notably observed as coupling between the STN beta phase and cortical broadband gamma (∼50-200 Hz) amplitude, and 3) prolonged beta bursts in the STN and cortex. In this review, we highlight relevant frequency and time domain features of STN beta measured in PD patients and summarize how spectral beta power, oscillatory beta synchrony, phase-amplitude coupling, and temporal beta bursting inform PD pathology, neurosurgical targeting, and DBS therapy. We then review how STN beta dynamics inform predictive, biomarker-driven aDBS approaches for optimizing PD treatment. We therefore provide clinically useful and actionable insight that can be applied toward aDBS implementation for PD.

BOARD-FTD-PACC: a graphical user interface for the synaptic and cross-frequency analysis derived from neural signals

In order to understand the link between brain functional states and behavioral/cognitive processes, the information carried in neural oscillations can be retrieved using different analytic techniques. Processing these different bio-signals is a complex, time-consuming, and often non-automatized process that requires customization, due to the type of signal acquired, acquisition method implemented, and the objectives of each individual research group. To this end, a new graphical user interface (GUI), named BOARD-FTD-PACC, was developed and designed to facilitate the visualization, quantification, and analysis of neurophysiological recordings. BOARD-FTD-PACC provides different and customizable tools that facilitate the task of analyzing post-synaptic activity and complex neural oscillatory data, mainly cross-frequency analysis. It is a flexible and user-friendly software that can be used by a wide range of users to extract valuable information from neurophysiological signals such as phase-amplitude coupling and relative power spectral density, among others. BOARD-FTD-PACC allows researchers to select, in the same open-source GUI, different approaches and techniques that will help promote a better understanding of synaptic and oscillatory activity in specific brain structures with or without stimulation.

EMG-driven control in lower limb prostheses: a topic-based systematic review

BACKGROUND

The inability of users to directly and intuitively control their state-of-the-art commercial prosthesis contributes to a low device acceptance rate. Since Electromyography (EMG)-based control has the potential to address those inabilities, research has flourished on investigating its incorporation in microprocessor-controlled lower limb prostheses (MLLPs). However, despite the proposed benefits of doing so, there is no clear explanation regarding the absence of a commercial product, in contrast to their upper limb counterparts.

OBJECTIVE AND METHODOLOGIES

This manuscript aims to provide a comparative overview of EMG-driven control methods for MLLPs, to identify their prospects and limitations, and to formulate suggestions on future research and development. This is done by systematically reviewing academical studies on EMG MLLPs. In particular, this review is structured by considering four major topics: (1) type of neuro-control, which discusses methods that allow the nervous system to control prosthetic devices through the muscles; (2) type of EMG-driven controllers, which defines the different classes of EMG controllers proposed in the literature; (3) type of neural input and processing, which describes how EMG-driven controllers are implemented; (4) type of performance assessment, which reports the performance of the current state of the art controllers.

RESULTS AND CONCLUSIONS

The obtained results show that the lack of quantitative and standardized measures hinders the possibility to analytically compare the performances of different EMG-driven controllers. In relation to this issue, the real efficacy of EMG-driven controllers for MLLPs have yet to be validated. Nevertheless, in anticipation of the development of a standardized approach for validating EMG MLLPs, the literature suggests that combining multiple neuro-controller types has the potential to develop a more seamless and reliable EMG-driven control. This solution has the promise to retain the high performance of the currently employed non-EMG-driven controllers for rhythmic activities such as walking, whilst improving the performance of volitional activities such as task switching or non-repetitive movements. Although EMG-driven controllers suffer from many drawbacks, such as high sensitivity to noise, recent progress in invasive neural interfaces for prosthetic control (bionics) will allow to build a more reliable connection between the user and the MLLPs. Therefore, advancements in powered MLLPs with integrated EMG-driven control have the potential to strongly reduce the effects of psychosomatic conditions and musculoskeletal degenerative pathologies that are currently affecting lower limb amputees.